The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis.
Vanessa Posener de AndradeFernando Henrique Carlos De SouzaGustavo Luiz Behrens PintoSamuel Katsuyuki ShinjoPublished in: Advances in rheumatology (London, England) (2021)
Anti-Jo-1 positivity was found in 8.5% of patients with definite DM. This autoantibody was associated with an antisynthetase syndrome phenotype and might predict clinical outcomes in patients with definite DM.